This is the very first book to focus on this new approach that will eventually aid in developing new diagnostic markers and therapies for controlling and treating heart disease - the number-one killer in the industrialized world.
Divided into two parts, the book describes not only the potentials, but also the limitations of these technologies. The editors, both well known within the scientific community, provide new insights into the biochemical and cellular mechanisms of cardiovascular disease, as well as covering the transition into clinical applications. In so doing, they highlight the various strategies and technical aspects so as to assist the growing number of researchers intending to utilize these approaches. The result is an excellent way of educating and informing graduate students, post-doctoral fellows as well as researchers in academia and industry about the latest developments in this area.
Jennifer E. Van Eyk
Genom Herz-Kreislauf-System Proteomanalyse
".this is a highly recommended book."Human Genomics".provides a timely integration of the emerging technologies of genomics, proteomics and drug discovery.suitable for all levels."Briefings in Functional Genomics and Proteomics, Vol 2(4), Feb 2004"This is a very good book, whose best virtue is that it reliably reflects the current status of genomics and proteomics in the cardiovascular area. The inclusion of both fields in the same book could be considered excessively ambitious, but the result is very positive.Overall, this is a highly recommended book, written by specialists in their fields, offering a clear and concise overview of the basis for, and latest developments in, cardiovascular genomics and proteomics."Fernando Vivanco, Fundación Jímenez Díaz, Madrid, SpainHuman Genomics 1/04"In summary, this book provides a strong foundation in genomic and proteomic methodology and will bring the reader to the forefront in the use of these tools in cardiovascular disease research."Alan T. RemaleyClinical Chemistry
()